Status:
RECRUITING
Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery
Lead Sponsor:
University of Split, School of Medicine
Collaborating Sponsors:
University Hospital of Split
Conditions:
Pterygium of Conjunctiva and Cornea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motil...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- adults (older than 18 years of age)
- both sexes
- primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons
- if the patients had a bilateral pterygium, only one eye will be operated
- Exclusion criteria:
- connective tissue disease
- prior eye surgery
- chronic use of topical drugs (anti-glaucoma drugs)
Exclusion
Key Trial Info
Start Date :
May 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT03321201
Start Date
May 8 2018
End Date
December 31 2026
Last Update
November 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Split
Split, Croatia, 21000